Ignyte Acquisition (IGNY) Competitors

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

$0.0052

0.00 (0.00%)

(As of 04/18/2024 ET)

Stock Analysis Chart Competitors Financials SEC Filings Social Media

IGNY vs. PKBO, STAB, HGEN, NOVNQ, AHPI, SCPS, PTEIQ, GNCA, GNCAQ, and ALVO

Should you be buying Ignyte Acquisition stock or one of its competitors? The main competitors of Ignyte Acquisition include Peak Bio (PKBO), Statera Biopharma (STAB), Humanigen (HGEN), NVN Liquidation (NOVNQ), Allied Healthcare Products (AHPI), Scopus BioPharma (SCPS), PolarityTE (PTEIQ), Genocea Biosciences (GNCA), Genocea Biosciences (GNCAQ), and Alvotech (ALVO). These companies are all part of the "medical" sector.

Ignyte Acquisition vs.

Ignyte Acquisition (NASDAQ:IGNY) and Peak Bio (NASDAQ:PKBO) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, community ranking, valuation, earnings, analyst recommendations and media sentiment.

: 61.1% of Ignyte Acquisition shares are held by institutional investors. 19.9% of Ignyte Acquisition shares are held by insiders. Comparatively, 19.9% of Peak Bio shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ignyte Acquisition
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
Peak Bio
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
: Ignyte Acquisition's return on equity of 365.46% beat Peak Bio's return on equity.
Company Net Margins Return on Equity Return on Assets
Ignyte Acquisition N/A 365.46% -0.83%
Peak Bio N/A N/A N/A
: In the previous week, Ignyte Acquisition's average media sentiment score of 0.00 equaled Peak Bio'saverage media sentiment score.
Company Overall Sentiment
Ignyte Acquisition Neutral
Peak Bio Neutral
: Ignyte Acquisition has higher earnings, but lower revenue than Peak Bio.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Ignyte Acquisition N/A N/A -$490K N/A N/A
Peak Bio $610K 0.19 -$13.09M N/A N/A
: Peak Bio received 1 more outperform votes than Ignyte Acquisition when rated by MarketBeat users.
Company Underperform Outperform
Ignyte Acquisition N/A N/A
Peak Bio Outperform Votes
1
100.00%
Underperform Votes
No Votes
: Ignyte Acquisition has a beta of 0.19, meaning that its share price is 81% less volatile than the S&P 500. Comparatively, Peak Bio has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ignyte Acquisition	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Peak Bio	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Company	Net Margins	Return on Equity	Return on Assets
Ignyte Acquisition	N/A	365.46%	-0.83%
Peak Bio	N/A	N/A	N/A

Company	Overall Sentiment
Ignyte Acquisition	Neutral
Peak Bio	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ignyte Acquisition	N/A	N/A	-$490K	N/A	N/A
Peak Bio	$610K	0.19	-$13.09M	N/A	N/A

Company	Underperform	Outperform
Ignyte Acquisition	N/A	N/A
Peak Bio	Outperform Votes 1 100.00%	Underperform Votes No Votes

Summary

Ignyte Acquisition and Peak Bio tied by winning 4 of the 8 factors compared between the two stocks.

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

Get Ignyte Acquisition News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IGNY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

IGNY vs. The Competition

Export to Excel

Metric	Ignyte Acquisition	Biological Products Industry	Medical Sector	NASDAQ Exchange
Market Cap	$38,000.00	$2.55B	$4.75B	$7.44B
Dividend Yield	N/A	2.29%	2.98%	4.00%
P/E Ratio	N/A	32.62	231.05	17.68
Price / Sales	N/A	277.54	2,318.55	84.57
Price / Cash	N/A	143.37	47.14	35.12
Price / Book	-0.02	3.53	4.58	4.19
Net Income	-$490,000.00	-$43.99M	$104.25M	$214.08M
7 Day Performance	N/A	-9.75%	-5.39%	-4.90%
1 Month Performance	N/A	-9.37%	-4.86%	-3.50%
1 Year Performance	N/A	1.09%	8.42%	3.81%

Ignyte Acquisition Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PKBO Peak Bio	0 of 5 stars	$0.01 flat	N/A	N/A	$118,000.00	$610,000.00	0.00	21
STAB Statera Biopharma	0 of 5 stars	$0.00 flat	N/A	-96.7%	$33,000.00	$1.49M	0.00	46	Negative News
HGEN Humanigen	0 of 5 stars	N/A	N/A	N/A	$24,000.00	$1.70M	0.00	6
NOVNQ NVN Liquidation	0 of 5 stars	$0.00 flat	N/A	N/A	$22,000.00	$23.68M	0.00	90
AHPI Allied Healthcare Products	0 of 5 stars	N/A	N/A	N/A	$16,000.00	$27.05M	0.00	189	News Coverage
SCPS Scopus BioPharma	0 of 5 stars	$0.00 flat	N/A	-95.0%	$105,000.00	N/A	0.00	13	News Coverage
PTEIQ PolarityTE	0 of 5 stars	$0.02 flat	N/A	N/A	$149,000.00	$810,000.00	-0.01	42	Gap Up
GNCA Genocea Biosciences	0 of 5 stars	N/A	N/A	N/A	$6,000.00	$1.91M	0.00	74	Analyst Report
GNCAQ Genocea Biosciences	0 of 5 stars	N/A	N/A	N/A	$6,000.00	$1.64M	0.00	74	High Trading Volume
ALVO Alvotech	0.1091 of 5 stars	$12.73 +1.8%	$12.67 -0.5%	+35.4%	$0.00	$93.38M	-5.24	1,026	News Coverage

Related Companies and Tools

Related Companies:

Top 10 Stock Comparisons

This page (NASDAQ:IGNY) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Ignyte Acquisition (IGNY) Competitors

IGNY vs. PKBO, STAB, HGEN, NOVNQ, AHPI, SCPS, PTEIQ, GNCA, GNCAQ, and ALVO

Ignyte Acquisition vs.

Summary

New MarketBeat Followers Over Time

IGNY vs. The Competition

Ignyte Acquisition Competitors List

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info